Kenvue Inc (KVUE) - Rentabilitas dodolan miturut bathi resik

Kenvue Inc - logo grafis emiten KVUE

Kenvue Inc. dominates the consumer health segment by developing scientific formulas and digital care. The net realization margin demonstrates stability, with the current level standing at 10.90, which helps avoid purchasing overvalued stocks. An efficient warehouse network eliminates product shortages, although geopolitics and inflation create risks of asset write-downs and consumers switching to cheaper alternatives.

KVUE: Margin dodolan resik Kenvue Health 21.02.2024 - 14.11.2026

Kenvue Corp (KVUE) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi pasar:
Analisis kabeh metrik perusahaan:Kenvue Inc.
Produk dadi Kenvue Inc

To minimize investment risks, Kenvue Inc. (KVUE) must filter out market noise by evaluating cost management efficiency through the share of net profit in every dollar of revenue. Analyzing the net profit margin trend on GURU.Markets, an investor will see how the dominance of the Tylenol and Listerine brands allows the company to pass inflation onto consumers, ensuring high operational resilience and fundamental business reliability.

Pesaing wigati

HLN: Margin dodolan resik|Verona Pharma PLC - Tingkat bathi resik|Margin resik Jyong Biotech Ltd|Margin dodolan resik Ligand Corp|Margin dodolan resik AMRX|Margin dodolan perusahaan Perrigo Company plc|Margin dodolan resik ALVO (Alvotech Biopharmaceuticals)|LQDA: Rentabilitas dodolan resik|Galapagos N.V. - Margin dodolan resik|ANIP - Margin dodolan resik|MNKD: Margin dodolan resik|amphastar.com (AMPH) - Margin dodolan resik|PCRX (Pacira Pharmaceuticals) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik ARS Pharmaceuticals, Inc. (SPRY)|Margin dodolan resik TBPH|AQST (Aquestive Therapeutics) - Tingkat bathi resik|scPharmaceuticals, Inc. - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik TECX|tonixpharma.com - Margin dodolan resik|Tingkat bathi resik SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Margin resik|Rentabilitas dodolan miturut bathi resik BioHarvest|Rentabilitas dodolan miturut bathi resik EXOZ|Rentabilitas dodolan miturut bathi resik Oramed Pharmaceuticals (ORMP)|Rentabilitas dodolan miturut bathi resik ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Rentabilitas dodolan resik|Margin dodolan resik ABVC (ABVC BioPharma Inc)|CPIX - Rentabilitas dodolan miturut bathi resik|Quantum BioPharma Corp - Margin dodolan resik|FGEN (fibrogen.com) - Rentabilitas dodolan resik|TELO (Telomir Pharmaceuticals) - Rentabilitas dodolan miturut bathi resik|Rani Therapeutics Holdings - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik SNYR|Margin resik rallybio.com RLYB|Margin dodolan resik LEXX|PULM (Pulmatrix, Inc.) - Tingkat bathi resik|Pheton Holdings - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Aptorum Group Limited APM|LYRA: Rentabilitas dodolan miturut bathi resik|IBO: Margin resik|TNFA: Margin dodolan resik|YCBD: Rentabilitas resik perusahaan|Margin resik PainReform Ltd|CYTO (altamiratherapeutics.com) - Rentabilitas resik perusahaan|Margin dodolan resik LIPO|OPTN - Margin resik|Margin resik pieris.com PIRS|Tingkat bathi resik PROC|PTPI - Margin resik|Qilian International Holding (QLI) - Rentabilitas dodolan miturut bathi resik|SLRN: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik TFF Pharma